The U.S. Food and Drug Administration has delayed a decision on whether to approve emergency use of Moderna's COVID-19 vaccine in 12- to 17-year-olds until at least January, the company announced Sunday. That's because the agency told the company on Friday that it needs more time to assess emerging international data on whether the vaccine […]
